A retrospective study on potential cross-reactivity between hypersensitivity reactions to taxanes and fosaprepitant.. If you have the appropriate software installed, you can download article citation ...

The following is a summary of “Discrepancies in Beta-Lactam Antibiotics Cross-Reactivity: Implications for Clinical Practice,” published in the February 2025 issue of European Journal of Allergy and ...

Vertex Pharmaceuticals (VRTX) is facing technical challenges, with its stock forming a Death Cross and down 15% in 6 months.

Chart of the Day: Don't Forget About Beta August 09, 2024 — 09:34 am EDT Written by Jim Van Meerten for Barchart -> ...

De-escalation of beta-lactam antibiotics was associated with a decreased risk of new resistance development compared with no change in beta-lactam antibiotic use, researchers found.

Prolonged infusion of beta-lactam antibiotics for sepsis or septic shock tended to improve mortality compared with conventional intermittent infusion in the BLING III trial, and a meta-analysis ...

The role that Epstein-Barr Virus (EBV) plays in the development of Multiple Sclerosis may be caused a higher level of cross-reactivity, where the body's immune system binds to the wrong target ...

Full-dose challenges were safely conducted for ED patients with moderate, severe, or unknown beta-lactam allergies, thereby avoiding unnecessary penicillin skin testing and reducing suboptimal ...

Contamination of Brexafemme with a non-antibacterial beta-lactam drug could lead to reactions such as swelling, rash, urticaria and anaphylaxis. Scynexis is recalling two lots of Brexafemme ...

Risk Statement: The potential cross contamination with a non-antibacterial beta-lactam drug substance could lead to hypersensitivity reactions such as swelling, rash, urticaria and anaphylaxis, a ...